Cook Medical reports new findings on sex-specific medical technology

Cook Medical has announced the publication of key findings from a unique sex and gender Symposium.

It said these results will help progress the development of sex-specific medical technology for the treatment of vascular diseases.

The Impact of Sex in Vascular Diseases and Implications for Therapies meeting uncovered a series of knowledge gaps in relation to the condition, risk factors, its symptoms and responses to treatment.

It was found basic biological makeup of blood vessels and the heart differs between men and women and can have a direct impact on the diagnosis, prevention and treatment of stroke, heart attacks and other types of vascular disease.

Furthermore, oestrogen and other reproductive hormones were found to influence the progression of these conditions.

Christina Anne, vice-president of the women’s health business unit at Cook Medical, said: “These preliminary findings will have a significant impact on how the medical device industry designs and develops medical technology and therapies for vascular medicine.”

She added a one-size-fits-all approach to medical technology should not be considered effective when treating female and male patients.

The company said it would work closely with those who participated in the symposium to provide minimally-invasive medical devices that address differences in gender.

Last month Cook Medical announced the launch of the Ciaglia Blue Dolphin for percutaneous trascheostomy procedures.